Unpublished studies reveal that the serial use (3 intravenous doses of MSCs with an average of 3 million cells) of MSCs in feline asthma causes a significant improvement of the disease, causing a drop in eosinophilia and an increase in cytokines which are anti-inflammatory.

Moreover, these studies show that stem cells can be applied serially without showing any reaction on the donor.